Page last updated: 2024-09-03

dx 9065a and Pulmonary Edema

dx 9065a has been researched along with Pulmonary Edema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enkhbaatar, P; Murakami, K; Okabe, H; Okabe, K; Okajima, K; Uchiba, M; Yamaguchi, Y	1

Other Studies

1 other study(ies) available for dx 9065a and Pulmonary Edema

Article	Year
Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:5 Topics: Animals; Anticoagulants; Capillary Permeability; Dansyl Compounds; Factor VIIa; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; In Vitro Techniques; Leukocytes; Lipopolysaccharides; Lipoproteins; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Naphthalenes; Neutrophil Activation; Peroxidase; Propionates; Pulmonary Edema; Rats; Rats, Wistar; Recombinant Proteins; Tumor Necrosis Factor-alpha	2000

Article

Year

Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.

American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:5

Topics: Animals; Anticoagulants; Capillary Permeability; Dansyl Compounds; Factor VIIa; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; In Vitro Techniques; Leukocytes; Lipopolysaccharides; Lipoproteins; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Naphthalenes; Neutrophil Activation; Peroxidase; Propionates; Pulmonary Edema; Rats; Rats, Wistar; Recombinant Proteins; Tumor Necrosis Factor-alpha

2000